Cargando…
Aberrant Glycogen Synthase Kinase 3β Is Involved in Pancreatic Cancer Cell Invasion and Resistance to Therapy
BACKGROUND AND PURPOSE: The major obstacles to treatment of pancreatic cancer are the highly invasive capacity and resistance to chemo- and radiotherapy. Glycogen synthase kinase 3β (GSK3β) regulates multiple cellular pathways and is implicated in various diseases including cancer. Here we investiga...
Autores principales: | Kitano, Ayako, Shimasaki, Takeo, Chikano, Yuri, Nakada, Mitsutoshi, Hirose, Mayumi, Higashi, Tomomi, Ishigaki, Yasuhito, Endo, Yoshio, Takino, Takahisa, Sato, Hiroshi, Sai, Yoshimichi, Miyamoto, Ken-ichi, Motoo, Yoshiharu, Kawakami, Kazuyuki, Minamoto, Toshinari |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3568118/ https://www.ncbi.nlm.nih.gov/pubmed/23408967 http://dx.doi.org/10.1371/journal.pone.0055289 |
Ejemplares similares
-
Aberrant glycogen synthase kinase 3β in the development of pancreatic cancer
por: Shimasaki, Takeo, et al.
Publicado: (2012) -
Metabolic Disorder, Inflammation, and Deregulated Molecular Pathways Converging in Pancreatic Cancer Development: Implications for New Therapeutic Strategies
por: Motoo, Yoshiharu, et al.
Publicado: (2011) -
Glycogen synthase kinase‐3β is a pivotal mediator of cancer invasion and resistance to therapy
por: Domoto, Takahiro, et al.
Publicado: (2016) -
Characterization of proteins secreted by pancreatic cancer cells with anticancer drug treatment in vitro
por: TAKATA, TAKANOBU, et al.
Publicado: (2012) -
Potential therapeutic effect of targeting glycogen synthase kinase 3β in esophageal squamous cell carcinoma
por: Bolidong, Dilireba, et al.
Publicado: (2020)